Literature DB >> 3921452

Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus.

P Bruneval, J M Foidart, D Nochy, J P Camilleri, J Bariety.   

Abstract

The diagnosis of light chain deposition nephropathy is based on the immunohistochemical demonstration of monoclonal light chain deposits within connective tissue matrix and on the presence at the ultrastructural level of electron-dense granular deposits along glomerular and tubular basement membranes. A nodular glomerulopathy characterized by amorphous periodic acid-Schiff-positive and argyrophilic widened mesangium and nodules is described in three patients with light chain deposition nephropathy. Light microscopic examination did not allow discrimination between the glomerular changes found in these specimens and the nodular glomerulosclerosis described in four patients with well-documented diabetes mellitus. Electron microscopic examination revealed microtubular fibrils 10 to 12 nm thick in mesangial areas in both groups. Such microfibrils could be glycoproteins. Immunofluorescence localization of matrix proteins, by staining with affinity-purified antibodies to types I, III, IV, and V (A, B) collagens, fibronectin, laminin, and heparan sulfate-containing proteoglycans, showed similar distributions in the two conditions. The mechanism of this abnormal accumulation of mesangial and glomerular basement membrane matrix proteins in two different conditions remains unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921452     DOI: 10.1016/s0046-8177(85)80086-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  Activation of protein kinase C isoforms and its impact on diabetic complications.

Authors:  Pedro Geraldes; George L King
Journal:  Circ Res       Date:  2010-04-30       Impact factor: 17.367

2.  Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus.

Authors:  P Muona; S Jaakkola; R Z Zhang; T C Pan; L Pelliniemi; L Risteli; M L Chu; J Uitto; J Peltonen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

3.  High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.

Authors:  S H Ayo; R A Radnik; J A Garoni; W F Glass; J I Kreisberg
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

4.  Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.

Authors:  C W Yang; H Vlassara; E P Peten; C J He; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Increased expression of basement membrane components in human endothelial cells cultured in high glucose.

Authors:  E Cagliero; M Maiello; D Boeri; S Roy; M Lorenzi
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

6.  Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

Authors:  T Doi; H Vlassara; M Kirstein; Y Yamada; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Aging-associated changes in renal extracellular matrix.

Authors:  C K Abrass; M J Adcox; G J Raugi
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

8.  Diabetic nephropathy. Mechanisms of mesangial matrix expansion.

Authors:  C K Abrass
Journal:  West J Med       Date:  1995-04

9.  Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment.

Authors:  Swapnil Rane; Seema Rana; Chetan Mudrabettu; Vivekananda Jha; Kusum Joshi
Journal:  Clin Kidney J       Date:  2012-10

10.  Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

Authors:  E Y Skolnik; Z Yang; Z Makita; S Radoff; M Kirstein; H Vlassara
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.